Trial intelligence / Profile preview

Comparison of Two Chemotherapy Regimens in Relapsed Non-Small Cell Lung Cancer After Surgery and Perioperative Chemotherapy

2007-001997-97Phase 3Completed

Sponsor
IFCT
Start
May 2007
Modality
Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 3 trial of docetaxel, cisplatin in non-small cell lung cancer (NSCLC), sponsored by IFCT. Started May 2007; status: completed.

02

Drugs

docetaxelcisplatin
03

Conditions

non-small cell lung cancer (NSCLC)

Beyond the preview

Go deeper on 2007-001997-97.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-001997-97.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call